IPX056

· Impax Laboratories, LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IPX056, covering 2019-11-06 to 2019-11-06. Get the full timeline:

Most recent: Clinical Trial Update: IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis [Phase 3]